
Department of Rheumatology and Clinical Immunology
The Department of Rheumatology and Clinical Immunology invites applications for a doctoral research position (PhD). The position is embedded in the DFG-funded Research Unit (RU) 5930, a multidisciplinary collaboration focusing on the identification and characterization of antibodies targeting G protein-coupled receptors (GPCR) and their role in vascular diseases such as pulmonary arterial hypertension and atherosclerosis. Vascular diseases often cause serious illnesses and have a significant impact on the quality of life of those affected. To investigate the underlying immunological mechanisms, we are seeking a committed doctoral student (PhD) (m/f/d) to work on subproject 6 of the DFG-funded RU 5930.
The aim of the subproject is to investigate the contribution of autoantibodies against the platelet-activating factor PAR1 to the aggravation and prognosis of vascular diseases. The project encompasses a broad spectrum of methods, including:
Start in our team
Within the RU 5930 the subproject P06 “Role of Protease-activated receptor (PAR) autoantibodies in aggravation and outcome of vascular diseases” led by Prof. Dr. Gabriela Riemekasten at the Department of Rheumatology & Clinical Immunology is seeking a PhD candidate at the earliest possible date The funding period is up to four years
What we offer:
Your tasks:
Your profile:
Please submit your application until 08th April 2026, indicating the reference number 28155 Please include the following documents with your application:

The University Hospital Schleswig-Holstein (UKSH) with its locations in Kiel and Lübeck is one of the largest medical care centers in Europe. It serves to warrant maximum medical care in the northernmost federal state and guarantees medical-technical care at the highest level, especially for patients who require highly differentiated diagnosis and therapy. The unique feature of university medicine is the interaction of health care, research and teaching with the result that scientific findings flow directly into the health system. The UKSH maintains the entire spectrum of medicine and multidisciplinary centers, cares for patients with rare diseases and extreme medical costs, operates university outpatient clinics and provides emergency care. The UKSH is the only maximum provider in Schleswig-Holstein. With 16,000 employees in over 85 clinics and institutes, UKSH is the largest employer and training provider in Schleswig-Holstein. Strategic personnel development, corporate health management and the certified compatibility of work and family life are integral parts of the corporate culture.
Imprint:
https://www.uksh.de/Impressum.html
Data protection:
https://www.uksh.de/privacy.html#socialmedia